All chronic hepatitis B articles
-
NewsNew study reveals a safer alternative for long-term hepatitis B treatment
Researchers have studied the effects of switching from long-term tenofovir disoproxil fumarate to the antiviral besifovir dipivoxil maleatein (BSV) in patients with chronic hepatitis B. Switching to BSV may improve patient kidney and bone health.
-
News‘Treat all’ strategy for patients with chronic hepatitis B virus infection
A new review explores the implications of a ’Treat-all’ strategy for chronic hepatitis B management following the 2022 Chinese guidelines which expanded treatment indications and simplified algorithms to enhance disease management.